Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2

被引:133
|
作者
Shirogane, Yuta [1 ]
Takeda, Makoto [1 ]
Iwasaki, Masaharu [1 ]
Ishiguro, Nobuhisa [2 ]
Takeuchi, Hiroki [1 ]
Nakatsu, Yuichiro [1 ]
Tahara, Maino [1 ]
Kikuta, Hideaki [3 ]
Yanagi, Yusuke [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan
[3] Touei Hosp, Pediat Clin, Higashi Ku, Sapporo, Hokkaido 0070841, Japan
关键词
D O I
10.1128/JVI.00676-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human metapneumovirus (HMPV) is a major causative agent of severe bronchiolitis and pneumonia. Its fusion (F) protein must be cleaved by host proteases to cause membrane fusion, a critical step for virus infection. By generating Vero cells constitutively expressing the transmembrane serine protease TMPRSS2 and green fluorescent protein-expressing recombinant HMPV, we show that TMPRSS2, which is expressed in the human lung epithelium, cleaves the HMPV F protein efficiently and supports HMPV multiplication. The results indicate that TMPRSS2 is a possible candidate protease involved in the development of lower respiratory tract illness in HMPV-infected patients.
引用
收藏
页码:8942 / 8946
页数:5
相关论文
共 50 条
  • [21] Changes in the Distribution of Type II Transmembrane Serine Protease, TMPRSS2 and in Paracellular Permeability in IPEC-J2 Cells Exposed to Oxidative Stress
    Erzsebet Paszti-Gere
    Reka Fanni Barna
    Csaba Kovago
    Ipoly Szauder
    Gabriella Ujhelyi
    Csaba Jakab
    Nóra Meggyesházi
    Andras Szekacs
    Inflammation, 2015, 38 : 775 - 783
  • [22] Changes in the Distribution of Type II Transmembrane Serine Protease, TMPRSS2 and in Paracellular Permeability in IPEC-J2 Cells Exposed to Oxidative Stress
    Paszti-Gere, Erzsebet
    Barna, Reka Fanni
    Kovago, Csaba
    Szauder, Ipoly
    Ujhelyi, Gabriella
    Jakab, Csaba
    Meggyeshazi, Nora
    Szekacs, Andras
    INFLAMMATION, 2015, 38 (02) : 775 - 783
  • [23] The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
    Wettstein, Lukas
    Kirchhoff, Frank
    Muench, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [24] In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2)
    Barge, Sagar
    Jade, Dhananjay
    Gosavi, Gokul
    Talukdar, Narayan Chandra
    Borah, Jagat
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 162
  • [25] Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity
    Villapalos-Garcia, Gonzalo
    Zubiaur, Pablo
    Rivas-Duran, Rebeca
    Campos-Norte, Pilar
    Arevalo-Roman, Cristina
    Fernandez-Rico, Marta
    Garcia-Fraile Fraile, Lucio
    Fernandez-Campos, Paula
    Soria-Chacartegui, Paula
    Fernandez de Cordoba-Onate, Sara
    Delgado-Wicke, Pablo
    Fernandez-Ruiz, Elena
    Gonzalez-Alvaro, Isidoro
    Sanz, Jesus
    Abad-Santos, Francisco
    de los Santos, Ignacio
    LIFE SCIENCE ALLIANCE, 2022, 5 (10)
  • [26] The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells
    Wilson, S
    Greer, B
    Hooper, J
    Zijlstra, A
    Walker, B
    Quigley, J
    Hawthorne, S
    BIOCHEMICAL JOURNAL, 2005, 388 : 967 - 972
  • [27] In mouse kidney endogenous transmembrane serine protease 2 (TMPRSS2) contributes to proteolytic processing and activation of the epithelial sodium channel (ENaC)
    Sure, Florian
    Afonso, Sara
    Schmidt, Paul
    Essigke, Daniel
    Kissler, Alicia
    Bertog, Marko
    Rinke, Ralf
    Wittmann, Sabine
    Gramberg, Thomas
    Artunc, Ferruh
    Korbmacher, Christoph
    Ilyaskin, Alexandr
    PHYSIOLOGY, 2023, 38
  • [28] Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2
    Zhu, Haixia
    Du, Wenhao
    Song, Menghua
    Liu, Qing
    Herrmann, Andreas
    Huang, Qiang
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 467 - 476
  • [29] TMPRSS2, a serine protease highly expressed in prostate cancer: A potential target for therapy
    True, LD
    Matsumura, M
    Moore, S
    Morrison, M
    Henneberg, R
    Nelson, PS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 174A - 174A
  • [30] Periodontitis promotes the expression of gingival transmembrane serine protease 2 (TMPRSS2), a priming protease for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Ohnishi, Tomokazu
    Nakamura, Toshiaki
    Shima, Kaori
    Noguchi, Kazuyuki
    Chiba, Norika
    Matsuguchi, Tetsuya
    JOURNAL OF ORAL BIOSCIENCES, 2022, 64 (02) : 229 - 236